Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1450

1.

Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Raitt MH, Klein RC, Wyse DG, Wilkoff BL, Beckman K, Epstein AE, Coromilas J, Friedman PL, Martins J, Ledingham RB, Greene HL; Antiarrhythmics Versus Implantable Defibrillators Investigators.

Am J Cardiol. 2003 Apr 1;91(7):812-6.

PMID:
12667566
2.

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.

Hallstrom AP, McAnulty JH, Wilkoff BL, Follmann D, Raitt MH, Carlson MD, Gillis AM, Shih HT, Powell JL, Duff H, Halperin BD; Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.

J Am Coll Cardiol. 2001 Mar 15;37(4):1093-9.

3.

Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators.

Steinberg JS, Beckman K, Greene HL, Marinchak R, Klein RC, Greer SG, Ehlert F, Foster P, Menchavez E, Raitt M, Wathen MS, Morris M, Hallstrom A.

J Cardiovasc Electrophysiol. 2001 Sep;12(9):996-1001.

PMID:
11573709
4.

Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.

Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB.

J Cardiovasc Electrophysiol. 2003 May;14(5):492-8.

PMID:
12776866
5.

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL; AVID Investigators.

J Cardiovasc Electrophysiol. 2003 Sep;14(9):940-8.

PMID:
12950538
7.

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Exner DV, Reiffel JA, Epstein AE, Ledingham R, Reiter MJ, Yao Q, Duff HJ, Follmann D, Schron E, Greene HL, Carlson MD, Brodsky MA, Akiyama T, Baessler C, Anderson JL.

J Am Coll Cardiol. 1999 Aug;34(2):325-33.

8.

Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.

Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP; AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.

Circulation. 2001 Apr 24;103(16):2066-71.

9.

Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators.

Rüppel R, Schlüter CA, Boczor S, Meinertz T, Schlüter M, Kuck KH, Cappato R.

J Am Coll Cardiol. 1998 Nov 15;32(6):1724-30.

10.

Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.

Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP.

J Am Coll Cardiol. 2004 Jun 16;43(12):2293-9.

11.

Postoperative ventricular arrhythmias after cardiac surgery: immediate- and long-term significance.

Brembilla-Perrot B, Villemot JP, Carteaux JP, Haouzi A, Amrein D, Schöth B, Houriez P, Beurrier D, Djaballah K, Vançon AC, Nippert M.

Pacing Clin Electrophysiol. 2003 Feb;26(2 Pt 1):619-25.

PMID:
12710323
12.

Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Brodsky MA, Mitchell LB, Halperin BD, Raitt MH, Hallstrom AP; AVID Investigators.

Am Heart J. 2002 Sep;144(3):478-84.

PMID:
12228785
13.

Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ; MADIT II Study Investigators.

J Am Coll Cardiol. 2006 Jan 3;47(1):98-107. Epub 2005 Dec 15.

14.

Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.

Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom A; AVID Investigators.

Am Heart J. 2001 Sep;142(3):520-9.

PMID:
11526368
16.

Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial.

Mitchell LB, Powell JL, Gillis AM, Kehl V, Hallstrom AP; AVID Investigators.

J Am Coll Cardiol. 2003 Jul 2;42(1):81-7.

17.

Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up.

Wyse DG, Friedman PL, Brodsky MA, Beckman KJ, Carlson MD, Curtis AB, Hallstrom AP, Raitt MH, Wilkoff BL, Greene HL; AVID Investigators.

J Am Coll Cardiol. 2001 Nov 15;38(6):1718-24.

18.

Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.

Glikson M, Lipchenca I, Viskin S, Ballman KV, Trusty JM, Gurevitz OT, Luria DM, Eldar M, Hammill SC, Friedman PA.

J Cardiovasc Electrophysiol. 2004 Jun;15(6):658-64.

PMID:
15175060
20.

Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.

Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.

Europace. 2006 Aug;8(8):618-24.

PMID:
16864615

Supplemental Content

Support Center